Latest Capital Raising And Placements News

Deal headlines and big drill hits shared the stage with a brutal sell-off in a handful of tiny raisings. The week’s biggest winners were backed by clear news; the biggest losers showed what happens when buyers vanish after a halt.

Small caps stole the spotlight, with a handful of stocks doubling on deal news and early-stage project updates. Large miners were steadier, but even they couldn’t fully escape the week’s sharp gap moves.

Horizon Minerals has successfully raised A$175 million through a two-tranche institutional placement, complemented by a planned A$10 million share purchase plan, to fund the development of its Black Swan Processing Hub near Kalgoorlie.

Trek Metals has raised $15 million through a strongly supported share placement to fund a major drilling campaign at its promising Kuro manganese discovery in Western Australia’s Kimberley region.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

A single drill program in WA delivered a once-a-year spike, while several small caps fell hard after reopening with price gaps. This week also saw big money raised for gold and uranium builds, and a run of resource upgrades across critical minerals.

A single diagnostics update sparked a breakout week, while a handful of biotech names sold off hard despite busy newsflow. Capital raisings, takeover steps and US market pushes kept healthcare in motion heading into mid-February milestones.

Memphasys has raised $800,000 through a share placement to accelerate the commercial expansion of its Felix™ System, following key regulatory approvals and initial revenue milestones.

Orbminco Limited reports promising interim infill drilling results at its Majestic North Gold Project, confirming high-grade shallow gold zones and potential southern extensions. The company also secures $5 million in a two-tranche placement to accelerate resource delineation and development.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

Patagonia Lithium Ltd has successfully raised A$2.9 million through a private placement, aiming to fast-track drilling and feasibility studies at its flagship Formentera Project in Argentina.

Bellavista Resources Ltd has agreed to acquire a majority stake in the high-grade Pickle Crow Gold Project in Ontario, Canada, boasting a 2.8 million ounce inferred resource at 7.2g/t gold. The company is also raising up to A$25 million to fund aggressive exploration and development.